Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiration, Artificial | 9 | 2023 | 114 | 2.670 |
Why?
|
| Respiratory Insufficiency | 11 | 2023 | 52 | 2.070 |
Why?
|
| Ventilator Weaning | 5 | 2023 | 37 | 1.310 |
Why?
|
| Oxygen Inhalation Therapy | 5 | 2022 | 20 | 1.130 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2017 | 25 | 1.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2020 | 53 | 0.910 |
Why?
|
| Prone Position | 11 | 2023 | 36 | 0.810 |
Why?
|
| Oxygen | 4 | 2023 | 73 | 0.770 |
Why?
|
| Positive-Pressure Respiration | 1 | 2021 | 11 | 0.770 |
Why?
|
| Intensive Care Units | 2 | 2022 | 301 | 0.680 |
Why?
|
| Hospitals | 1 | 2020 | 156 | 0.650 |
Why?
|
| Hypoxia | 3 | 2021 | 36 | 0.640 |
Why?
|
| Wakefulness | 10 | 2023 | 98 | 0.600 |
Why?
|
| Epoprostenol | 1 | 2017 | 7 | 0.570 |
Why?
|
| Metered Dose Inhalers | 2 | 2017 | 5 | 0.570 |
Why?
|
| Tidal Volume | 2 | 2017 | 13 | 0.570 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 31 | 0.560 |
Why?
|
| Albuterol | 1 | 2017 | 19 | 0.550 |
Why?
|
| Bronchodilator Agents | 1 | 2017 | 21 | 0.540 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 81 | 0.540 |
Why?
|
| Humans | 33 | 2023 | 28395 | 0.500 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 328 | 0.470 |
Why?
|
| Aerosols | 3 | 2020 | 23 | 0.450 |
Why?
|
| Respiration | 2 | 2017 | 35 | 0.450 |
Why?
|
| Quality of Life | 3 | 2018 | 658 | 0.440 |
Why?
|
| Helium | 1 | 2013 | 1 | 0.430 |
Why?
|
| Carbon Dioxide | 1 | 2013 | 20 | 0.420 |
Why?
|
| Patient Positioning | 6 | 2023 | 41 | 0.420 |
Why?
|
| Exercise | 1 | 2017 | 473 | 0.420 |
Why?
|
| Lung | 4 | 2023 | 170 | 0.420 |
Why?
|
| Ventilators, Mechanical | 3 | 2023 | 23 | 0.400 |
Why?
|
| Intubation, Intratracheal | 4 | 2023 | 99 | 0.400 |
Why?
|
| Respiratory Muscles | 2 | 2023 | 18 | 0.390 |
Why?
|
| Noninvasive Ventilation | 2 | 2022 | 11 | 0.380 |
Why?
|
| Airway Extubation | 3 | 2022 | 10 | 0.380 |
Why?
|
| Middle Aged | 10 | 2023 | 9250 | 0.330 |
Why?
|
| Hospital Mortality | 2 | 2021 | 147 | 0.310 |
Why?
|
| Respiratory Therapy | 2 | 2020 | 14 | 0.290 |
Why?
|
| Administration, Inhalation | 2 | 2017 | 45 | 0.280 |
Why?
|
| Male | 11 | 2023 | 15269 | 0.280 |
Why?
|
| Female | 11 | 2023 | 15704 | 0.270 |
Why?
|
| Allied Health Personnel | 2 | 2023 | 11 | 0.250 |
Why?
|
| Adult | 6 | 2023 | 8097 | 0.250 |
Why?
|
| Health Personnel | 1 | 2005 | 107 | 0.230 |
Why?
|
| Suction | 2 | 2023 | 40 | 0.220 |
Why?
|
| Infection Control | 2 | 2020 | 166 | 0.210 |
Why?
|
| Certification | 1 | 2023 | 49 | 0.200 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2021 | 4 | 0.190 |
Why?
|
| APACHE | 2 | 2021 | 31 | 0.180 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 36 | 0.180 |
Why?
|
| Particulate Matter | 1 | 2020 | 20 | 0.180 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 76 | 0.170 |
Why?
|
| Aged | 6 | 2020 | 9256 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 733 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 1215 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 90 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 94 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2023 | 3609 | 0.150 |
Why?
|
| Humidifiers | 1 | 2017 | 2 | 0.140 |
Why?
|
| Airway Resistance | 1 | 2017 | 5 | 0.140 |
Why?
|
| Pulmonary Ventilation | 1 | 2017 | 10 | 0.140 |
Why?
|
| Decontamination | 1 | 2017 | 10 | 0.140 |
Why?
|
| Cannula | 3 | 2022 | 14 | 0.140 |
Why?
|
| Models, Anatomic | 1 | 2017 | 39 | 0.140 |
Why?
|
| Patient Education as Topic | 2 | 2016 | 160 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 18 | 0.140 |
Why?
|
| Perception | 1 | 2017 | 78 | 0.140 |
Why?
|
| Dry Powder Inhalers | 1 | 2016 | 3 | 0.140 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2016 | 6 | 0.140 |
Why?
|
| Teaching Materials | 1 | 2016 | 9 | 0.140 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2017 | 20 | 0.140 |
Why?
|
| Vibration | 1 | 2017 | 30 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2023 | 1804 | 0.130 |
Why?
|
| Pilot Projects | 2 | 2016 | 439 | 0.120 |
Why?
|
| Health Literacy | 1 | 2016 | 108 | 0.120 |
Why?
|
| Algorithms | 1 | 2017 | 377 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2021 | 931 | 0.120 |
Why?
|
| Capnography | 1 | 2013 | 10 | 0.110 |
Why?
|
| Pressure | 1 | 2013 | 64 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 194 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 730 | 0.070 |
Why?
|
| Child | 2 | 2023 | 1421 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3615 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2008 | 81 | 0.070 |
Why?
|
| Young Adult | 1 | 2013 | 2069 | 0.070 |
Why?
|
| Students, Health Occupations | 1 | 2005 | 5 | 0.060 |
Why?
|
| Respiratory Tract Diseases | 1 | 2005 | 7 | 0.060 |
Why?
|
| School Admission Criteria | 1 | 2005 | 12 | 0.060 |
Why?
|
| Educational Measurement | 1 | 2005 | 61 | 0.060 |
Why?
|
| Tomography | 1 | 2023 | 13 | 0.050 |
Why?
|
| Atrophy | 1 | 2023 | 93 | 0.050 |
Why?
|
| Pneumonia | 1 | 2003 | 77 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 35 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 27 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 28 | 0.050 |
Why?
|
| Equivalence Trials as Topic | 1 | 2020 | 2 | 0.050 |
Why?
|
| Sarcopenia | 1 | 2021 | 31 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 42 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2023 | 655 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 492 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 77 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 121 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 329 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 260 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 2408 | 0.040 |
Why?
|
| Fear | 1 | 2018 | 46 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2018 | 126 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 932 | 0.040 |
Why?
|
| Work of Breathing | 1 | 2017 | 6 | 0.040 |
Why?
|
| Mucus | 1 | 2017 | 7 | 0.040 |
Why?
|
| Biofilms | 1 | 2017 | 16 | 0.040 |
Why?
|
| Mobility Limitation | 1 | 2018 | 94 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 110 | 0.040 |
Why?
|
| Inhalation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Anxiety | 1 | 2018 | 161 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2016 | 39 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 163 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 268 | 0.030 |
Why?
|
| Learning | 1 | 2016 | 73 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1490 | 0.030 |
Why?
|
| United States | 1 | 2020 | 2196 | 0.030 |
Why?
|
| Economics, Pharmaceutical | 1 | 2008 | 3 | 0.020 |
Why?
|
| Health Behavior | 1 | 2008 | 165 | 0.020 |
Why?
|
| Hospitalization | 1 | 2008 | 323 | 0.020 |
Why?
|
| Humidity | 1 | 2003 | 1 | 0.010 |
Why?
|